SR9009 10 Stenabolic

Stenabolic (SR 9009), a promising PPAR alpha modifier drug that has garnered attention since its development by Professor Thomas Burris of the renowned Scripps Research Institute. While still in the developmental phase as of 2015, this compound is gaining popularity as both a SARM and research chemical. Comparable to Cardarine (GW-501516) as a Rev-ErbA agonist, Stenabolic has been hailed as the “exercise in a bottle” due to its ability to enhance exercise capacity by boosting mitochondria in skeletal muscle, as reported by “National Medicine.”

Metabolic Boost and Endurance Enhancement

Stenabolic works by modifying the activity of skeletal muscle mitochondria, leading to increased metabolic activity. This unique mechanism is akin to the effects of DNP but without the counterproductive impact on endurance goals. Unlike DNP, SR 9009 can simulate the benefits of aerobic exercise without requiring extensive conditioning. As a result, your endurance is elevated, allowing you to surpass previous limits.

The Role of Rev-erbA and Fat Burning

(SR 9009) binds to Rev-erbA, a protein crucial for regulating fat and sugar metabolism in the liver, fat cell production, and the body’s inflammatory responses. This interaction between SR 9009 and Rev-erbA supercharges your current exercise regimen, making it more effective. Surprisingly, even a sedentary lifestyle won’t hinder your progress. The ultimate goal is to utilize the energy from your diet instead of storing it as fat, a feat in which SR 9009 excels. Moreover, it targets existing fat, facilitating its breakdown and utilization as energy.

Unveiling Results

Stenabolic (SR 9009) promotes leanness and enhances cardio performance, allowing you to cover longer distances without getting winded quickly. It significantly improves your VO2 max, amplifying your endurance potential. Beyond athletes, SR 9009 also shows promise for non-athletes, as it has demonstrated the ability to combat obesity, metabolic syndrome, and type 2 diabetes.

Insights from Mice Studies

In studies involving mice with low muscle mass, sluggish metabolism, and poor running capacity—similar to out-of-shape individuals—administration of Stenabolic resulted in increased muscle mass and metabolic rate, even without exercise. When these mice were given the opportunity to exercise, they exhibited a remarkable 50% increase in running distance before experiencing fatigue.

Considerations for Side Effects

Unlike fat burners, thyroid accelerators, or appetite suppressants such as clenbuterol, T3, or certain stimulants, SR 9009 does not induce crashes or fatigue. However, as Stenabolic is a relatively new compound with limited human athlete usage, further research is required to identify any potential undesired effects.

Optimal Dosage and Usage

To maximize the benefits of Stenabolic, a daily dosage of 20-30 milligrams (mg) is recommended, with adjustments of 10 mg based on individual preference. The typical cycle duration ranges from 6 to 8 weeks, and for enhanced endurance power, it is advisable to stack SR 9009 with Cardarine (GW-501516).

It’s important to note that Stenabolic has a relatively short half-life compared to Cardarine, necessitating 3-4 daily doses. However, some users have reported successful outcomes with dosing at 2-3 times per day.

Unleash your potential with Stenabolic (SR 9009), harnessing its transformative effects to elevate your performance, boost metabolism, and redefine your limits. Experience the power of this groundbreaking compound, revolutionizing your journey towards

PACKAGE CONTENT:

1 Box of 2x 25Tablets, 10mg per Tablet.